<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000306505">
  <TermName>BCX-1777</TermName>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor. Also called forodesine hydrochloride.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>BCX-1777</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de leucemia y linfoma. Es un tipo de inhibidor de la enzima purina-nucleósido fosforilasa (PNP). También se llama clorhidrato de forodesina.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-05-23</DateFirstPublished>
  <DateLastModified>2007-06-19</DateLastModified>
</GlossaryTerm>
